Intractable Self-harm-What Support is Effective?
ConditionSelf-harm
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRegion Skane
About this trial
The aim of this project is to evaluate a novel treatment program for individuals with intractable and lethal self-harm.
The main questions are:
1: Is there, in individuals with intractable self-harm, a relevant improvement in daily functioning and is this improvement related to the provided interventions?
The secondary research questions are:
2\. Is there, in individuals with intractable self-harm, a relevant improvement in frequency and severity of self-harm?
3\. Is there, in individuals with intractable self-harm, a relevant improvement in voluntary hospital admissions?
4\. Is there, in individuals with intractable self-harm, a relevant improvement in compulsary hospital admissions?
5\. Is there, in individuals with intractable self-harm, a relevant improvement in the use of medication pro re nata?
6\. Is there, in individuals with intractable self-harm, a relevant improvement in cost-effectiveness related to the provided interventions?
Eligibility criteria
Qualifiers
Having tried or made serious attempt to try at least two different interventions with evidence to reduce self-harm, without sufficient reduction in suffering or self-harm
Disqualifiers
Need for translation services to complete measures or interviews
Not able to complete measures or interviews
Trial design
Treatments tested in this trial
- National specialized medical care unit for severe self-harm behaviour-Consultation model
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Region Skane
Lead sponsor
Department of Psychology. Lund University.
Collaborator
Department of Clinical Sciences, Malmö. Faculty of Medicine, Lund University.
Collaborator
Source ClinicalTrials.gov